Thesis, the wellness start-up with a customized approach to cognitive performance products based on brain chemistry, closed on a Series A round totaling $8.4 million.
WHO: New York-based DTC brand Thesis offers potent nutrient compounds formulated to enhance mental performance based on your unique brain chemistry and the cognitive states you want to achieve. Dan Freed founded Thesis in 2017, recognizing that nootropics are not a one-size-fits-all wellness category. Thesis is customized to each person’s unique brain chemistry by allowing customers to experiment with the highest-quality nootropic ingredients systematically to maximize results. For $79, the initial assessment takes one month to test different formulas and find the combinations of ingredients that work best for each person. All products are manufactured in the United States in facilities following FDA supplement manufacturing guidelines.
WHY: The new capital will support Thesis as it makes key executive hires, expands its product selection, and undergoes clinical trials. The company has 30 employees, which will double over the next year as roles in customer experience, product development, and marketing are added.
IN THEIR OWN WORDS: “Nootropics have helped me a great deal, as someone who originally struggled in school and who eventually went on to graduate from some of the world’s most prestigious universities. I spent a significant amount of time learning about these compounds and finding the blend that worked for me. It shouldn’t be so hard,” said Dan Freed, founder and CEO of Thesis. “I created Thesis products for people who feel that they might not be living up to their full potential and want a real solution to close the gap.”
Rachel Harris, Partner at Unilever Ventures, said, “In today’s 'always on' world, consumers are increasingly looking for solutions to optimize their mental acuity and the demand for products that allow you to perform at your best has never been greater. With Thesis’s customized offering, education-focused and digital-first model rooted in a highly compelling founder story, we have been impressed by Dan’s vision and the exacting standards that he is setting for the brand. We are excited to support him on the next chapter of the business’s growth.”
“I am excited to be part of Dan’s vision of customized health and wellness solutions. Thesis is defining a new wellness category and reshaping how people approach brain care," said Michael Lynton, Thesis Board Director.
DETAILS:
